Reflex sympathetic dystrophy.
Schott
G D
GD
Pain Management Department, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK. geoffrey.schott@uclh.org
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001340:Autonomic Nerve Block; D002490:Central Nervous System / Q000503:physiopathology; D018755:GABA Agonists / Q000627:therapeutic use; D006801:Humans; D017933:Peripheral Nervous System / Q000503:physiopathology; D026741:Physical Therapy Modalities; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors; D012019:Reflex Sympathetic Dystrophy / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D012307:Risk Factors; D026941:Sodium Channel Blockers; D013564:Sympathetic Nervous System / Q000503:physiopathology; D016896:Treatment Outcome
D000929:Antidepressive Agents, Tricyclic; D018755:GABA Agonists; D016194:Receptors, N-Methyl-D-Aspartate; D026941:Sodium Channel Blockers